Several studies describe mutations in TβRI and TβRII in adenomas and gliomas[148,149] as well as correlation between higher expression of TβRI and TβRII with more aggressive glioma cell lines and tumors[150,151]. Here, TGFBR2 is linked to central nervous system cancer.